101 related articles for article (PubMed ID: 7865236)
1. Heat-stable alkaline phosphatase. A putative tumor marker of head and neck squamous cell carcinoma.
Rassam MB; al-Bashir NN; al-Salihi AR; Hammash MH; al-Sammerai FT; al-Ubaidi MA; Waheed IN
Acta Oncol; 1995; 34(1):49-52. PubMed ID: 7865236
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
Bhattacharjee A; Giri S; Roy M; Chakraborty A
J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patients.
Patel PS; Patel BP; Rawal RM; Raval GN; Patel MM; Patel JB; Jha FP; Patel DD
Tumour Biol; 2000; 21(2):82-9. PubMed ID: 10686537
[TBL] [Abstract][Full Text] [Related]
4. Significance of alkaline phosphatase and chemotherapy for head and neck carcinoma.
Burres SA; Jacobs JR; Peppard SB; Al-Sarraf M
Otolaryngol Head Neck Surg; 1982; 90(2):188-92. PubMed ID: 6180367
[TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer. Relationship of the prechemotherapy serum alkaline phosphatase levels to response rate of induction chemotherapy.
Coker DD; Morris D; Elias EG; Didolkar MS; Zentai TA
Arch Otolaryngol; 1982 Jan; 108(1):28-9. PubMed ID: 6172102
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the value of fluorometric serum heat stable alkaline phosphatase assay in patients operated on for ovarian tumors.
Kallioniemi OP; Heinonen PK; Pystynen P; Koivula T
Tumour Biol; 1985; 6(3):213-9. PubMed ID: 4070936
[TBL] [Abstract][Full Text] [Related]
8. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
Clin Lab; 2016 Aug; 62(8):1569-1574. PubMed ID: 28164611
[TBL] [Abstract][Full Text] [Related]
9. Prognostic indicators in chemotherapy for head and neck carcinoma: alkaline phosphatase levels.
Katz AE; Hong WK; Bhutani R; Berman LD; Blanchard GJ; Koff RS; Shapshay SM; Strong MS
Laryngoscope; 1980 Jun; 90(6 Pt 1):924-9. PubMed ID: 7382708
[TBL] [Abstract][Full Text] [Related]
10. Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck.
Doweck I; Barak M; Greenberg E; Uri N; Kellner J; Lurie M; Gruener N
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):177-81. PubMed ID: 7530966
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase activity of tumors in the head and neck].
Kagata HY; Tsukuda M; Mochimatsu I; Kubota A; Furukawa MK; Yasumoto S
Nihon Jibiinkoka Gakkai Kaiho; 1998 Feb; 101(2):205-11. PubMed ID: 9545766
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Zhang S; Dong M; Teng X; Chen T
Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):581-5. PubMed ID: 11346437
[TBL] [Abstract][Full Text] [Related]
13. Serum leucine aminopeptidase in head and neck cancer.
Garg LN; Yadav SP; Lal H
J Laryngol Otol; 1994 Aug; 108(8):660-2. PubMed ID: 7930914
[TBL] [Abstract][Full Text] [Related]
14. Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients.
John K; Rösner I; Keilholz U; Gauler T; Bantel H; Grünwald V
Eur J Cancer; 2015 Aug; 51(12):1596-602. PubMed ID: 26048456
[TBL] [Abstract][Full Text] [Related]
15. Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck.
Ferruzzi E; Franceschini R; Cazzolato G; Geroni C; Fowst C; Pastorino U; Tradati N; Tursi J; Dittadi R; Gion M
Eur J Cancer; 2003 May; 39(7):1019-29. PubMed ID: 12706373
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
[TBL] [Abstract][Full Text] [Related]
17. Serum samples should not be used to assess circulating matrix metalloproteinase-9 levels as a prognostic marker of disease.
Tanus-Santos JE; Gerlach RF
Int J Cancer; 2006 Feb; 118(3):789; author reply 790. PubMed ID: 16094623
[No Abstract] [Full Text] [Related]
18. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2, 12-lipoxygenase, and inducible nitric oxide synthase in head and neck squamous cell carcinoma.
Celenk F; Bayramoglu I; Yilmaz A; Menevse A; Bayazit Y
J Craniofac Surg; 2013 Jul; 24(4):1114-7. PubMed ID: 23851751
[TBL] [Abstract][Full Text] [Related]
20. Utility of abdominal imaging to assess for liver metastasis in patients with head and neck cancer and abnormal liver function tests.
Chen PG; Schoeff SS; Watts CA; Reibel JF; Levine PA; Shonka DC; Jameson MJ
Am J Otolaryngol; 2014; 35(2):137-40. PubMed ID: 24315629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
